Feature Review Collection in Pharmaceutical Technology
Share This Topical Collection
Editor
Topical Collection Information
Dear Colleagues,
With the continual discovery of a plethora of new drug candidates, both small-molecule drugs and large biomolecules, pharmaceutical technologies are becoming essential for advancements in patient treatments. These might include drug modifications, new formulations, or the use of delivery devices for drugs with unfavorable pharmacokinetic properties; the development of drug screening platforms that capture physiological complexity; technology developments that enable novel therapeutics to be scaled up and manufactured; the development of assays for drug discovery, testing, or validation; or technologies enabling drug delivery regimens that improve patient compliance.
This Special Issue aims to feature reviews on enabling pharmaceutical technologies. These may include any technology related to the discovery, testing, analysis, approval, delivery, and manufacturing of pharmaceutics as well as their use in patients. Submissions to this Special Issue should include a cover letter stating the novelty of the review article in comparison to related reviews published in the literature.
Prof. Dr. Serge Mordon
Collection Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the collection website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceuticals is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript.
The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs).
Submitted papers should be well formatted and use good English. Authors may use MDPI's
English editing service prior to publication or during author revisions.
Keywords
- pharmaceutical technology
- drug delivery
- drug screening
- drug modification
- drug testing
- drug validation
- drug formulation
- assay development
- drug discovery
- medicinal chemistry
Published Papers (2 papers)
2025
Open AccessReview
Scale-Agnostic Models Based on Dimensionless Quality by Design as Pharmaceutical Development Accelerator
by
Miquel Romero-Obon, Virginia Sancho-Ochoa, Khadija Rouaz-El-Hajoui, Pilar Pérez-Lozano, Marc Suñé-Pou, Josep María Suñé-Negre and Encarna García-Montoya
Viewed by 217
Abstract
This comprehensive review of the synergistic use of Quality by Design (QbD) and the Pi–Buckingham theorem explores an innovative approach to enhancing product development and process optimization within the pharmaceutical industry. QbD is a systematic, proactive methodology that integrates quality considerations throughout the
[...] Read more.
This comprehensive review of the synergistic use of Quality by Design (QbD) and the Pi–Buckingham theorem explores an innovative approach to enhancing product development and process optimization within the pharmaceutical industry. QbD is a systematic, proactive methodology that integrates quality considerations throughout the product lifecycle to ensure that pharmaceutical products meet regulatory standards for safety and efficacy from the outset of development. The Pi–Buckingham theorem serves as a foundational principle in dimensional analysis, facilitating the simplification of complex models by transforming physical variables into dimensionless parameters. This synergy enables researchers to better understand and control the factors affecting critical quality attributes (CQAs), thereby improving manufacturing outcomes and minimizing variability.
Full article
►▼
Show Figures
Open AccessReview
Advanced Nanomaterials Functionalized with Metal Complexes for Cancer Therapy: From Drug Loading to Targeted Cellular Response
by
Bojana B. Zmejkovski, Nebojša Đ. Pantelić and Goran N. Kaluđerović
Viewed by 532
Abstract
Developments of nanostructured materials have a significant impact in various areas, such as energy technology and biomedical use. Examples include solar cells, energy management, environmental control, bioprobes, tissue engineering, biological marking, cancer diagnosis, therapy, and drug delivery. Currently, researchers are designing multifunctional nanodrugs
[...] Read more.
Developments of nanostructured materials have a significant impact in various areas, such as energy technology and biomedical use. Examples include solar cells, energy management, environmental control, bioprobes, tissue engineering, biological marking, cancer diagnosis, therapy, and drug delivery. Currently, researchers are designing multifunctional nanodrugs that combine in vivo imaging (using fluorescent nanomaterials) with targeted drug delivery, aiming to maximize therapeutic efficacy while minimizing toxicity. These fascinating nanoscale “magic bullets” should be available in the near future. Inorganic nanovehicles are flexible carriers to deliver drugs to their biological targets. Most commonly, mesoporous nanostructured silica, carbon nanotubes, gold, and iron oxide nanoparticles have been thoroughly studied in recent years. Opposite to polymeric and lipid nanostructured materials, inorganic nanomaterial drug carriers are unique because they have shown astonishing theranostic (therapy and diagnostics) effects, expressing an undeniable part of future use in medicine. This review summarizes research from development to the most recent discoveries in the field of nanostructured materials and their applications in drug delivery, including promising metal-based complexes, platinum, palladium, ruthenium, titanium, and tin, to tumor cells and possible use in theranostics.
Full article
►▼
Show Figures
